Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Biotechnology Letters
|
November 4, 2018
A non-specific nucleolytic enzyme and its application potential in EDTA-containing buffer solutions
Sarah Schmitz, Volker Nölle, Skander Elleuche
Applied Microbiology and Biotechnology
|
February 23, 2020
Bacterial non-specific nucleases of the phospholipase D superfamily and their biotechnological potential
Lynn Sophie Schwardmann, Volker Nölle, Skander Elleuche
Molecular Biotechnology
|
November 22, 2019
Characterization of Single Amino Acid Variations in an EDTA-Tolerating Non-specific Nuclease from the Ice-Nucleating Bacterium Pseudomonas syringae
Sarah Schmitz, Marek Wieczorek, Volker Nölle, et al.
Applied Microbiology and Biotechnology
|
January 28, 2019
Comparative analysis of two non-specific nucleases of the phospholipase D family from the plant pathogen competitor bacterium Pantoea agglomerans
Sarah Schmitz, Paul Börner, Volker Nölle, et al.
Applied Microbiology and Biotechnology
|
August 11, 2022
Design of a novel switchable antibody display system in Pichia pastoris
Dominic Gätjen, Florian Tomszak, Johann-Christoph Dettmann, et al.
Journal of Immunological Methods
|
November 10, 2022
A switchable secrete-and-capture system enables efficient selection of Pichia pastoris clones producing high yields of Fab fragments
Dominic Gätjen, Marek Wieczorek, Martin Listek, et al.
Applied Microbiology and Biotechnology
|
August 21, 2016
Purification of bone morphogenetic protein-2 from refolding mixtures using mixed-mode membrane chromatography
Gesa Gieseler, Iliyana Pepelanova, Lena Stuckenberg, et al.
Biotechnology Reports (Amsterdam, Netherlands)
|
June 8, 2018
Solubilization and renaturation of biologically active human bone morphogenetic protein-4 from inclusion bodies
Gesa-Maria Gieseler, Kimia Ekramzadeh, Volker Nölle, et al.
Iscience
|
March 17, 2023
Preclinical safety and efficacy of a therapeutic antibody that targets SARS-CoV-2 at the sotrovimab face but is escaped by Omicron
Jakob Kreye, S Momsen Reincke, Stefan Edelburg, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Biotechnology Letters
|
November 4, 2018
A non-specific nucleolytic enzyme and its application potential in EDTA-containing buffer solutions
Sarah Schmitz, Volker Nölle, Skander Elleuche
Applied Microbiology and Biotechnology
|
February 23, 2020
Bacterial non-specific nucleases of the phospholipase D superfamily and their biotechnological potential
Lynn Sophie Schwardmann, Volker Nölle, Skander Elleuche
Molecular Biotechnology
|
November 22, 2019
Characterization of Single Amino Acid Variations in an EDTA-Tolerating Non-specific Nuclease from the Ice-Nucleating Bacterium Pseudomonas syringae
Sarah Schmitz, Marek Wieczorek, Volker Nölle, et al.
Applied Microbiology and Biotechnology
|
January 28, 2019
Comparative analysis of two non-specific nucleases of the phospholipase D family from the plant pathogen competitor bacterium Pantoea agglomerans
Sarah Schmitz, Paul Börner, Volker Nölle, et al.
Applied Microbiology and Biotechnology
|
August 11, 2022
Design of a novel switchable antibody display system in Pichia pastoris
Dominic Gätjen, Florian Tomszak, Johann-Christoph Dettmann, et al.
Journal of Immunological Methods
|
November 10, 2022
A switchable secrete-and-capture system enables efficient selection of Pichia pastoris clones producing high yields of Fab fragments
Dominic Gätjen, Marek Wieczorek, Martin Listek, et al.
Applied Microbiology and Biotechnology
|
August 21, 2016
Purification of bone morphogenetic protein-2 from refolding mixtures using mixed-mode membrane chromatography
Gesa Gieseler, Iliyana Pepelanova, Lena Stuckenberg, et al.
Biotechnology Reports (Amsterdam, Netherlands)
|
June 8, 2018
Solubilization and renaturation of biologically active human bone morphogenetic protein-4 from inclusion bodies
Gesa-Maria Gieseler, Kimia Ekramzadeh, Volker Nölle, et al.
Iscience
|
March 17, 2023
Preclinical safety and efficacy of a therapeutic antibody that targets SARS-CoV-2 at the sotrovimab face but is escaped by Omicron
Jakob Kreye, S Momsen Reincke, Stefan Edelburg, et al.
Page
of 1